These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 21539452

  • 1. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor.
    Yuan S, Qiao T, Chen W.
    Cancer Biother Radiopharm; 2011 Apr; 26(2):203-8. PubMed ID: 21539452
    [Abstract] [Full Text] [Related]

  • 2. CpG oligodeoxynucleotide enhances tumor response to radiation.
    Milas L, Mason KA, Ariga H, Hunter N, Neal R, Valdecanas D, Krieg AM, Whisnant JK.
    Cancer Res; 2004 Aug 01; 64(15):5074-7. PubMed ID: 15289307
    [Abstract] [Full Text] [Related]

  • 3. The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model.
    Zhang M, Yin T, Lu Y, Feng H.
    Med Sci Monit; 2016 Apr 19; 22():1309-17. PubMed ID: 27092689
    [Abstract] [Full Text] [Related]

  • 4. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
    Mason KA, Ariga H, Neal R, Valdecanas D, Hunter N, Krieg AM, Whisnant JK, Milas L.
    Clin Cancer Res; 2005 Jan 01; 11(1):361-9. PubMed ID: 15671567
    [Abstract] [Full Text] [Related]

  • 5. CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
    Mason KA, Neal R, Hunter N, Ariga H, Ang K, Milas L.
    Radiother Oncol; 2006 Aug 01; 80(2):192-8. PubMed ID: 16905212
    [Abstract] [Full Text] [Related]

  • 6. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Gekeler V, Gimmnich P, Hofmann HP, Grebe C, Römmele M, Leja A, Baudler M, Benimetskaya L, Gonser B, Pieles U, Maier T, Wagner T, Sanders K, Beck JF, Hanauer G, Stein CA.
    Oligonucleotides; 2006 Aug 01; 16(1):83-93. PubMed ID: 16584297
    [Abstract] [Full Text] [Related]

  • 7. Enhancing radiosensitivity of human pulmonary adenocarcinoma cell line A549 by CpG ODN1826.
    Li R, Song Y, Chen W.
    Cancer Biother Radiopharm; 2011 Feb 01; 26(1):69-76. PubMed ID: 21355778
    [Abstract] [Full Text] [Related]

  • 8. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM.
    Immunology; 2004 Oct 01; 113(2):212-23. PubMed ID: 15379982
    [Abstract] [Full Text] [Related]

  • 9. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
    Zhang Y, Shoda LK, Brayton KA, Estes DM, Palmer GH, Brown WC.
    J Interferon Cytokine Res; 2001 Oct 01; 21(10):871-81. PubMed ID: 11711000
    [Abstract] [Full Text] [Related]

  • 10. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM.
    J Leukoc Biol; 2004 Sep 01; 76(3):585-93. PubMed ID: 15218053
    [Abstract] [Full Text] [Related]

  • 11. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9.
    Pohar J, Lainšček D, Fukui R, Yamamoto C, Miyake K, Jerala R, Benčina M.
    J Immunol; 2015 Nov 01; 195(9):4396-405. PubMed ID: 26416273
    [Abstract] [Full Text] [Related]

  • 12. TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.
    Sommariva M, De Cecco L, De Cesare M, Sfondrini L, Ménard S, Melani C, Delia D, Zaffaroni N, Pratesi G, Uva V, Tagliabue E, Balsari A.
    Cancer Res; 2011 Oct 15; 71(20):6382-90. PubMed ID: 21878529
    [Abstract] [Full Text] [Related]

  • 13. B cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinoma.
    Sorrentino R, Morello S, Forte G, Montinaro A, De Vita G, Luciano A, Palma G, Arra C, Maiolino P, Adcock IM, Pinto A.
    Am J Respir Crit Care Med; 2011 May 15; 183(10):1369-79. PubMed ID: 21278302
    [Abstract] [Full Text] [Related]

  • 14. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
    Masuda Y, Nawa D, Nakayama Y, Konishi M, Nanba H.
    J Leukoc Biol; 2015 Dec 15; 98(6):1015-25. PubMed ID: 26297795
    [Abstract] [Full Text] [Related]

  • 15. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
    Arunkumar N, Liu C, Hang H, Song W.
    Cell Mol Immunol; 2013 Jul 15; 10(4):360-72. PubMed ID: 23727784
    [Abstract] [Full Text] [Related]

  • 16. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors.
    Daftarian P, Song GY, Ali S, Faynsod M, Longmate J, Diamond DJ, Ellenhorn JD.
    Cancer Res; 2004 Aug 01; 64(15):5407-14. PubMed ID: 15289349
    [Abstract] [Full Text] [Related]

  • 17. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
    Ballas ZK, Rasmussen WL, Krieg AM.
    J Immunol; 1996 Sep 01; 157(5):1840-5. PubMed ID: 8757300
    [Abstract] [Full Text] [Related]

  • 18. Dose-effect relationship of CpG oligodeoxyribonucleotide 1826 in murine Lewis lung cancer treated with irradiation.
    Zhuang X, Qiao T, Yuan S, Chen W, Zha L, Yan L.
    Onco Targets Ther; 2013 Sep 01; 6():549-54. PubMed ID: 23723711
    [Abstract] [Full Text] [Related]

  • 19. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T, Wen ZK, Liu ZM, Qian C, Liang YJ, Jin ML, Cai YY, Xu L.
    Cancer Invest; 2008 Jun 01; 26(5):448-55. PubMed ID: 18568766
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of radiosensitivity by CpG-oligodeoxyribonucleotide-7909 in human non-small cell lung cancer A549 cells.
    Zha L, Qiao T, Yuan S, Lei L.
    Cancer Biother Radiopharm; 2010 Apr 01; 25(2):165-70. PubMed ID: 20423229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.